Changyuan Lu

MedicineNursing

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease”.

A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease

Journal of Biological Chemistry(2021)10.1016/j.jbc.2021.101331

N/A

0DataRank · unranked

27 citations

Marta Melis, Changyuan Lu, Andrew Rappa, Tuo Zhang, José Jessurun +3 more

Retinoic acid receptor α activity in proximal tubules prevents kidney injury and fibrosis

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2311803121

N/A

0DataRank · unranked

20 citations

Xiao‐Han Tang, Leiping Fu, Mary E. Choi, Changyuan Lu, Lorraine J. Gudas +1 more